Let’s talk about management of hepatitis B.
We have interferons for hepatitis B.
We have peginterferon,
we have interferon alpha.
Please memorize the alpha for hepatitis B.
And limited duration of therapy,
high side effect burden is what you’re worried about,
especially with interferons.
Management continues and we have antiviral drugs
such as Lamivudine, resistance oftentimes seen.
We have Entecavir,
You'll notice, we have the suffix, -vir, -vir, -vir.
Your focus should be on viral hepatitis, specifically B.
And we have -vir, virus.
Usually indefinite therapy concern.
But the only thing is you’re worried about
resistance in this patient with hepatitis B.
Antiviral drugs that you want to be familiar with.
Obviously, your focus should also be on prevention.
Let’s begin the vaccination.
The vaccination therapy and the regimen
is something that you want to be
very familiar with coming off of immunology.
If you're not, it will be a good time to go back
and make sure that you take a look at
vaccination regimen for hepatitis B,
specifically, please, perinatal exposure,
universal vaccination for all children.
Now, whatever your personal belief would be on vaccination,
at this point, you keep that to yourself.
I highly recommend that
hemodialysis patients, men who have sex with men,
IV drug abusers, persons with recent exposure
and patients with chronic liver disease.
This is your population in which you need to make sure
that you prevent hepatitis B from developing.